Status:
UNKNOWN
Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Pancreatic Neoplasms
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Thermal therapy (hyperthermia, or heat) enhances the chemotherapy anti-tumor kill. Thermal therapy by itself also kills cancer cells. Whole-body thermotherapy is a systemic treatment that includes the...
Detailed Description
The treatment cycle begins with 6 hours of intravenous (IV) hydration followed by an infusion of the anti-cancer drug, Cisplatin. In addition, at the beginning of this treatment, you will begin low-do...
Eligibility Criteria
Inclusion
- Candidate must have biopsy-documented locally advanced or metastatic pancreas cancer
- Must be able to successfully complete preliminary function tests
- Must have a good ECOG score
- Must have two functioning lungs
Exclusion
- Must not have active metastasis to the brain
- Must not have poor preliminary function tests
- Must not have a low ECOG score
- Must not be taking high-dose corticosteroids
- Must be psychologically stable
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00178763
Start Date
September 1 2003
End Date
June 1 2013
Last Update
March 3 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital
Houston, Texas, United States, 77030